Dr Josh D Gast, DO | |
304 S Mount Auburn Rd, Cape Girardeau, MO 63703-4920 | |
(573) 803-2941 | |
(573) 803-0815 |
Full Name | Dr Josh D Gast |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 13 Years |
Location | 304 S Mount Auburn Rd, Cape Girardeau, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437404761 | NPI | - | NPPES |
1437404761 | Other | COMMERCIAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 03680 (Kentucky) | Secondary |
207R00000X | Internal Medicine | 2011018182 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Poplar Bluff Regional Medical Center | Poplar bluff, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Big Springs Medical Association | 6709871007 | 36 |
News Archive
In a post in USAID's "IMPACTblog," CARE President and CEO Helene Gayle describes a new multi-partner initiative, called "Women and Girls Lead Global," which aims to spread "the stories of ... resilient women and girls" through documentary films that will air in nine countries over three years.
The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.
Medicaid programs - reimbursement for providers in Texas, proposed cuts in Illinois and application delays in Connecticut - make news.
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
› Verified 9 days ago
Entity Name | Big Springs Medical Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225045321 PECOS PAC ID: 6709871007 Enrollment ID: O20040416000695 |
News Archive
In a post in USAID's "IMPACTblog," CARE President and CEO Helene Gayle describes a new multi-partner initiative, called "Women and Girls Lead Global," which aims to spread "the stories of ... resilient women and girls" through documentary films that will air in nine countries over three years.
The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.
Medicaid programs - reimbursement for providers in Texas, proposed cuts in Illinois and application delays in Connecticut - make news.
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
› Verified 9 days ago
Entity Name | Pemiscot County Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578668661 PECOS PAC ID: 8426024159 Enrollment ID: O20070326000204 |
News Archive
In a post in USAID's "IMPACTblog," CARE President and CEO Helene Gayle describes a new multi-partner initiative, called "Women and Girls Lead Global," which aims to spread "the stories of ... resilient women and girls" through documentary films that will air in nine countries over three years.
The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.
Medicaid programs - reimbursement for providers in Texas, proposed cuts in Illinois and application delays in Connecticut - make news.
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
› Verified 9 days ago
Entity Name | Butler Physician Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982056545 PECOS PAC ID: 6608164561 Enrollment ID: O20161007001160 |
News Archive
In a post in USAID's "IMPACTblog," CARE President and CEO Helene Gayle describes a new multi-partner initiative, called "Women and Girls Lead Global," which aims to spread "the stories of ... resilient women and girls" through documentary films that will air in nine countries over three years.
The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.
Medicaid programs - reimbursement for providers in Texas, proposed cuts in Illinois and application delays in Connecticut - make news.
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
› Verified 9 days ago
Entity Name | Alliance Health And Dermatology, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952958449 PECOS PAC ID: 5597094961 Enrollment ID: O20190910002484 |
News Archive
In a post in USAID's "IMPACTblog," CARE President and CEO Helene Gayle describes a new multi-partner initiative, called "Women and Girls Lead Global," which aims to spread "the stories of ... resilient women and girls" through documentary films that will air in nine countries over three years.
The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.
Medicaid programs - reimbursement for providers in Texas, proposed cuts in Illinois and application delays in Connecticut - make news.
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Josh D Gast, DO 335 Hidden Meadows Dr, Jackson, MO 63755-3274 Ph: (573) 986-8923 | Dr Josh D Gast, DO 304 S Mount Auburn Rd, Cape Girardeau, MO 63703-4920 Ph: (573) 803-2941 |
News Archive
In a post in USAID's "IMPACTblog," CARE President and CEO Helene Gayle describes a new multi-partner initiative, called "Women and Girls Lead Global," which aims to spread "the stories of ... resilient women and girls" through documentary films that will air in nine countries over three years.
The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.
Medicaid programs - reimbursement for providers in Texas, proposed cuts in Illinois and application delays in Connecticut - make news.
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
› Verified 9 days ago
Kenneth W Retter, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 211 Saint Francis Dr Ste 15, Cape Girardeau, MO 63703 Phone: 573-331-3333 | |
Dr. Aaron Lang, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1723 Broadway St, Suite 315, Cape Girardeau, MO 63701 Phone: 573-332-0226 Fax: 573-332-0344 | |
Philip W Taylor, M.D., FACP Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3250 Gordonville Rd, Ste 301, Cape Girardeau, MO 63703 Phone: 573-334-9641 Fax: 573-331-3120 | |
Tibebe Haile, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Lacey St, Cape Girardeau, MO 63701 Phone: 573-331-6431 Fax: 573-986-5984 | |
Dr. Tiffany Renae Samples, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5770 Fax: 573-331-3974 | |
Narjes F Alamri, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3250 Gordonville Rd Ste 301, Cape Girardeau, MO 63703 Phone: 573-334-9641 Fax: 573-331-4130 | |
Rebecca L Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Suite 15, Cape Girardeau, MO 63703 Phone: 573-331-3333 Fax: 573-331-3334 |